ACOG: Neutralizing Antibodies and Cytokines in Breast Milk After Coronavirus Disease 2019 (COVID-19) mRNA Vaccination

ABSTRACT OBJECTIVE: To evaluate immune responses to coronavirus disease 2019 (COVID-19) mRNA-based vaccines present in breast milk and transfer of the immune responses to breastfeeding infants. METHODS: We enrolled 30…

Read More from ACOG: Neutralizing Antibodies and Cytokines in Breast Milk After Coronavirus Disease 2019 (COVID-19) mRNA Vaccination

SMFM updated, “Provider Considerations for Engaging in COVID-19 Vaccine Counseling With Pregnant and Lactating Patients,” to include the latest information on boosters.

SMFM and ACOG recommend that pregnant people receive a COVID-19 booster shot at least 6 months after their primary series for mRNA-based vaccines (ie, Pfizer or Moderna) and at least…

Read More from SMFM updated, “Provider Considerations for Engaging in COVID-19 Vaccine Counseling With Pregnant and Lactating Patients,” to include the latest information on boosters.

ACOG: Scientific Evidence Supporting Coronavirus Disease 2019 (COVID-19) Vaccine Efficacy and Safety in People Planning to Conceive or Who Are Pregnant or Lactating

ABSTRACT Three coronavirus disease 2019 (COVID-19) vaccines have been authorized for use in the United States; specifically, the Pfizer–BioNTech, Moderna, and Johnson & Johnson–Janssen COVID-19 vaccines were granted emergency use…

Read More from ACOG: Scientific Evidence Supporting Coronavirus Disease 2019 (COVID-19) Vaccine Efficacy and Safety in People Planning to Conceive or Who Are Pregnant or Lactating

ACOG Green Journal: Associations Between Maternal Depression, Antidepressant Use During Pregnancy, and Adverse Pregnancy Outcomes

ABSTRACT OBJECTIVE: To evaluate the associations of depressive symptoms and antidepressant use during pregnancy with the risks of preterm birth, low birth weight, small for gestational age (SGA), and low…

Read More from ACOG Green Journal: Associations Between Maternal Depression, Antidepressant Use During Pregnancy, and Adverse Pregnancy Outcomes

ACOG Green Journal: Evaluation of a Risk-Stratified, Heparin-Based, Obstetric Thromboprophylaxis Protocol

ABSTRACT OBJECTIVE: To evaluate outcomes before and after implementation of a risk-stratified heparin-based obstetric thromboprophylaxis protocol. METHODS: We performed a retrospective cohort study of all patients who delivered at our…

Read More from ACOG Green Journal: Evaluation of a Risk-Stratified, Heparin-Based, Obstetric Thromboprophylaxis Protocol

ACOG Green Journal: Reduction in Cesarean Delivery Rates Associated With a State Quality Collaborative in Maryland

ABSTRACT OBJECTIVE: To assess the extent to which hospitals participating in the MDPQC (Maryland Perinatal-Neonatal Quality Care Collaborative) to reduce primary cesarean deliveries adopted policy and practice changes and the…

Read More from ACOG Green Journal: Reduction in Cesarean Delivery Rates Associated With a State Quality Collaborative in Maryland

ACOG Green Journal: Evaluation of an Initiative to Decrease the Use of Oxygen Supplementation for Category II Fetal Heart Rate Tracings

ABSTRACT OBJECTIVE: To examine compliance with a guideline to reduce exposure to supplemental oxygen for category II fetal heart rate (FHR) tracings in normally oxygenated laboring patients. METHODS: All patients…

Read More from ACOG Green Journal: Evaluation of an Initiative to Decrease the Use of Oxygen Supplementation for Category II Fetal Heart Rate Tracings

ACOG Green Journal: Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy Outcomes in a U.S. Population

ABSTRACT OBJECTIVE: To examine whether the coronavirus disease 2019 (COVID-19) pandemic altered risk of adverse pregnancy-related outcomes and whether there were differences by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)…

Read More from ACOG Green Journal: Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy Outcomes in a U.S. Population

ACOG Green Journal: Intrapartum Resuscitation Interventions for Category II Fetal Heart Rate Tracings and Improvement to Category I

ABSTRACT OBJECTIVE: To evaluate intrapartum resuscitation interventions and improvement in category II fetal heart rate (FHR) tracings. METHODS: This secondary analysis of a randomized trial of intrapartum fetal electrocardiographic ST-segment…

Read More from ACOG Green Journal: Intrapartum Resuscitation Interventions for Category II Fetal Heart Rate Tracings and Improvement to Category I

ACOG Green Journal: Relationship Between Umbilical Cord Gas Values and Neonatal Outcomes

ABSTRACT OBJECTIVE: To evaluate the relationship between umbilical artery cord gas values and fetal tolerance of labor, as reflected by Apgar score. We hypothesized the existence of wide biological variability…

Read More from ACOG Green Journal: Relationship Between Umbilical Cord Gas Values and Neonatal Outcomes

ACOG Committee Opinion, Number 826: Protecting and Expanding Medicaid to Improve Women’s Health

Abstract Medicaid, the state–federal health insurance program for individuals with low incomes, serves as a safety net for women throughout the life span. Historically, expansions of Medicaid have been associated…

Read More from ACOG Committee Opinion, Number 826: Protecting and Expanding Medicaid to Improve Women’s Health

ACOG Committee Opinion, Number 828: Indications for Outpatient Antenatal Fetal Surveillance

Abstract The purpose of this Committee Opinion is to offer guidance about indications for and timing and frequency of antenatal fetal surveillance in the outpatient setting. Antenatal fetal surveillance is…

Read More from ACOG Committee Opinion, Number 828: Indications for Outpatient Antenatal Fetal Surveillance

ACOG Committee Opinion, Number 831: Medically Indicated Late-Preterm and Early-Term Deliveries

Abstract The neonatal risks of late-preterm and early-term births are well established, and the potential neonatal complications associated with elective delivery at less than 39 0/7 weeks of gestation are…

Read More from ACOG Committee Opinion, Number 831: Medically Indicated Late-Preterm and Early-Term Deliveries